Get 20% Free Customization In This Report

Buy this report from - $3456

Consumer Healthcare Market by Product (OTC Pharmaceuticals and Dietary Supplements); and Distribution Network (Departmental Stores, Independent Retailers, Pharmacies or Drugstores, Specialist Retailers, and Supermarkets or Hypermarkets) - Global Opportunities and Industry Forecasts, 2017-2023

Healthcare	LI_183511	Pages: NA	Jun 2018 \| 763 Views
Author's : NA	Tables: NA	Charts: NA	Formats*:

Consumer healthcare deals with products in wellness, oral health, nutrition, and skin health. Consumer healthcare products mainly constitute over-the-counter (OTC) drugs that include medicines, which are sold directly to a consumer without a prescription from a healthcare professional.

The major factors that contribute to the growth of the consumer healthcare market include high demand for self-medication, growing healthcare costs, increasing geriatric population who are more prone to contracting diseases, deterioration in mental health, and shift from medication prescription to OTC products. Moreover, the approval of wellness & preventive medicine and a rise in disposable income further boosts the market growth. However, stringent governmental regulations and the presence of counterfeit pharmaceuticals restrain the market. On the contrary, development & accelerated use of online sources, along with the increasing demand for branded products, private labels, and OTC generics will further provide numerous opportunities in the near future.

The global consumer healthcare market is segmented on the basis of products, distribution network, and region. Based on product, it is bifurcated into OTC pharmaceuticals and dietary supplements. On the basis of distribution network, the market is categorized into departmental stores, independent retailers, pharmacies or drugstores, specialist retailers, and supermarkets or hypermarkets. Geographically, the market has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key players that operate in this market include Johnson & Johnson, Sanofi, Pfizer Inc., Abbott Laboratories, GlaxoSmithKline plc, Boehringer Ingelheim GmbH, Teva Pharmaceutical Industries Ltd., Bayer AG, Amway, and BASF SE.

Key Benefits

The study provides an in-depth analysis of the global consumer healthcare market with current trends and future estimations to elucidate imminent investment pockets.
The report provides information about the current and upcoming trends in the global consumer healthcare market from 2016 to 2023, which helps determine prevailing opportunities.
Comprehensive analysis of factors that drive and restrict the growth of the global consumer healthcare market has been provided.
Identification of factors that are instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on a global and regional scale have been provided.
Key market players within the market have been profiled in this report and their strategies thoroughly analyzed, which help understand the competitive outlook of the global consumer healthcare market.

Consumer Healthcare Market Key Segments:

By Product

OTC Pharmaceuticals
Dietary Supplements

By Distribution Network

Departmental Stores
Independent Retailers
Pharmacies or Drugstores
Specialist Retailers
Supermarkets or Hypermarkets

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Australia
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIE SUMMARY

2.1. CXO PERSPECTIE

Chapter: 3 MARKET OERIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top inestment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIE FORCES ANALYSIS

3.4.1. MARKET DYNAMICS
3.4.2. Driers
3.4.3. Restraints
3.4.4. Opportunities

Chapter: 4 CONSUMER HEALTHCARE MARKET, BY PRODUCT

4.1. OERIEW

4.1.1. Market size and forecast

4.2. OTC PHARMACEUTICALS

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. DIETARY SUPPLEMENTS

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

Chapter: 5 CONSUMER HEALTHCARE MARKET, BY DISTRIBUTION NETWORK

5.1. OERIEW

5.1.1. Market size and forecast

5.2. DEPARTMENTAL STORES

5.2.1. Market size and forecast

5.3. INDEPENDENT RETAILERS

5.3.1. Market size and forecast

5.4. PHARMACIES OR DRUGSTORES

5.4.1. Market size and forecast

5.5. SPECIALIST RETAILERS

5.5.1. Market size and forecast

5.6. SUPERMARKETS OR HYPERMARKETS

5.6.1. Market size and forecast

Chapter: 6 CONSUMER HEALTHCARE MARKET, BY REGION

6.1. OERIEW
6.2. NORTH AMERICA

6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast

6.2.3.1. U.S. market size and forecast
6.2.3.2. Canada market size and forecast
6.2.3.3. Mexico market size and forecast

6.2.4. North America consumer healthcare market by product
6.2.5. North America consumer healthcare market by distribution network

6.3. EUROPE

6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast

6.3.3.1. Germany market size and forecast
6.3.3.2. France market size and forecast
6.3.3.3. UK market size and forecast
6.3.3.4. Italy market size and forecast
6.3.3.5. Spain market size and forecast
6.3.3.6. Rest of Europe market size and forecast

6.3.4. Europe consumer healthcare market by product
6.3.5. Europe consumer healthcare market by distribution network

6.4. ASIA-PACIFIC

6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast

6.4.3.1. Japan market size and forecast
6.4.3.2. China market size and forecast
6.4.3.3. Australia market size and forecast
6.4.3.4. India market size and forecast
6.4.3.5. South Korea market size and forecast
6.4.3.6. Taiwan market size and forecast
6.4.3.7. Rest of Asia-Pacific market size and forecast

6.4.4. Asia-Pacific consumer healthcare market by product
6.4.5. Asia-Pacific consumer healthcare market by distribution network

6.5. LAMEA

6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast

6.5.3.1. Brazil market size and forecast
6.5.3.2. Turkey market size and forecast
6.5.3.3. Saudi Arabia market size and forecast
6.5.3.4. South Africa market size and forecast
6.5.3.5. Rest of LAMEA market size and forecast

6.5.4. LAMEA consumer healthcare market by product
6.5.5. LAMEA consumer healthcare market by distribution network

Chapter: 7 COMPANY PROFILES

7.1. JOHNSON & JOHNSON

7.1.1. Operating business segments
7.1.2. Business performance
7.1.3. Key strategic moes and deelopments

7.2. SANOFI

7.2.1. Operating business segments
7.2.2. Business performance
7.2.3. Key strategic moes and deelopments

7.3. PFIZER INC.

7.3.1. Operating business segments
7.3.2. Business performance
7.3.3. Key strategic moes and deelopments

7.4. ABBOTT LABORATORIES

7.4.1. Operating business segments
7.4.2. Business performance
7.4.3. Key strategic moes and deelopments

7.5. GLAXOSMITHKLINE PLC

7.5.1. Operating business segments
7.5.2. Business performance
7.5.3. Key strategic moes and deelopments

7.6. BOEHRINGER INGELHEIM GMBH

7.6.1. Operating business segments
7.6.2. Business performance
7.6.3. Key strategic moes and deelopments

7.7. TEA PHARMACEUTICAL INDUSTRIES LTD.

7.7.1. Operating business segments
7.7.2. Business performance
7.7.3. Key strategic moes and deelopments

7.8. BAYER AG

7.8.1. Operating business segments
7.8.2. Business performance
7.8.3. Key strategic moes and deelopments

7.9. AMWAY

7.9.1. Operating business segments
7.9.2. Business performance
7.9.3. Key strategic moes and deelopments

7.10. BASF SE

7.10.1. Operating business segments
7.10.2. Business performance
7.10.3. Key strategic moes and deelopments

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
Technologically sophisticated and reliable insights through well audited and veracious research methodology
Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

Patent and regulatory databases for understanding of technical & legal developments
Scientific and technical writings for product information and related preemptions
Regional government and statistical databases for macro analysis
Authentic new articles, web-casts and other related releases for market evaluation
Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

Validates and improves the data quality and strengthens research proceeds
Further develops analyst team’s market understanding and expertise
Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

Chief executives and VPs of leading corporations specific to industry
Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.